Page last updated: 2024-10-21

1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one and Osteoarthritis

1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one has been researched along with Osteoarthritis in 1 studies

1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one: structure given in first source; inhibits guanylyl cyclase
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one : A member of the class of oxadiazoloquinoxalines that is 1H-[1,2,4]oxadiazolo[4,3-a]quinoxaline substituted at position 1 by an oxo group.

Osteoarthritis: A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.

Research Excerpts

ExcerptRelevanceReference
"Tadalafil dose-dependently inhibited hypernociception in zymosan and osteoarthritis models."3.77Tadalafil analgesia in experimental arthritis involves suppression of intra-articular TNF release. ( Castro, RR; Cunha, FQ; Girão, VC; Leite, AC; Leite, AK; Rocha, FA; Silva, FS, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rocha, FA1
Silva, FS1
Leite, AC1
Leite, AK1
Girão, VC1
Castro, RR1
Cunha, FQ1

Other Studies

1 other study available for 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one and Osteoarthritis

ArticleYear
Tadalafil analgesia in experimental arthritis involves suppression of intra-articular TNF release.
    British journal of pharmacology, 2011, Volume: 164, Issue:2b

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Arthralgia; Arthritis, Experimental; Carbolines; Chem

2011